Pharmacokinetics of the selective PDE4 inhibitor Roflumilast and its active metabolite Roflumilast N-oxide are not affected by concomitant budesonide, salbutamol, or erythromycin*1

✍ Scribed by HAUNS, B

• Book ID: 119274097
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 26 KB
• Volume: 113
• Category: Article
• ISSN: 1097-6825
• DOI: 10.1016/j.jaci.2004.01.252